CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 27, 2014		Sep. 28, 2013		Sep. 27, 2014		Sep. 28, 2013
Sales	$ 5,613,216		$ 5,048,211		$ 16,371,795		$ 15,203,925
Costs and expenses:
Cost of sales	4,884,529		4,376,551		14,191,759		13,200,621
Selling, general, and administrative expenses	485,864		453,920		1,453,675		1,376,199
Depreciation and amortization	39,072		32,436		115,355		96,540
Restructuring, integration, and other charges	3,935		22,568		25,181		74,402
Total Costs and Expenses	5,413,400		4,885,475		15,785,970		14,747,762
Operating income	199,816		162,736		585,825		456,163
Equity in earnings of affiliated companies	2,192		1,884		4,790		5,227
Gain on sale of investment	29,743		0		29,743		0
Loss on prepayment of debt	0		0		0		4,277
Interest and other financing expense, net	27,522		27,167		86,079		86,896
Income before income taxes	204,229		137,453		534,279		370,217
Provision for income taxes	57,377		40,490		152,175		105,260
Consolidated net income	146,852		96,963		382,104		264,957
Noncontrolling interests	(12)		184		236		368
Net income attributable to shareholders	$ 146,864		$ 96,779		$ 381,868		$ 264,589
Net income per share:
Basic	$ 1.49		$ 0.96		$ 3.84		$ 2.56
Diluted	$ 1.47	[1]	$ 0.95	[1]	$ 3.80	[1]	$ 2.53	[1]
Weighted-average shares outstanding:
Basic	98,631		100,750		99,336		103,269
Diluted	99,866		101,669		100,609		104,426

[1] Stock-based compensation awards for the issuance of 317 and 271 shares for the third quarter and first nine months of 2014 and 831 and 871 for the third quarter and first nine months of 2013, respectively, were excluded from the computation of net income per share on a diluted basis as their effect was anti-dilutive.